Email "How Exact Sciences plans to capitalize on the FDA's expanded indication — Cologuard President Mark Stenhouse explains " to a Friend.

Your Friend's Email Address:

Your Name:

Your Email:

Enter the word "" without the quotes:

By submitting, you agree to Becker's Healthcare terms of service and privacy policy.